טוען...
Safety and effectiveness of bevacizumab in Japanese patients with malignant glioma: a post-marketing surveillance study
OBJECTIVE: This surveillance study was conducted to verify the post-market safety and effectiveness of bevacizumab, which was approved in Japan in 2013 for the treatment of patients with newly diagnosed and or recurrent malignant glioma. METHODS: This was a prospective, observational, multicenter po...
שמור ב:
| הוצא לאור ב: | Jpn J Clin Oncol |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Oxford University Press
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6923818/ https://ncbi.nlm.nih.gov/pubmed/31665343 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jjco/hyz125 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|